Abstract:Chemistry and Human Health, Division VII of the International Union on Pure and Applied Chemistry (IUPAC), provides guidance on risk assessment methodology and, as appropriate, assessment of risks to human health from chemicals of exceptional toxicity. The aim of this document is to describe dose-response relationships for the health effects of low-level exposure to cadmium, in particular, with an emphasis on causation. The term "cadmium" in this document includes all chemical species of cadmium, as well as those in cadmium compounds. Diet is the main source of cadmium exposure in the general population. Smokers and workers in cadmium industries have additional exposure. Adverse effects have been shown in populations with high industrial or environmental exposures. Epidemiological studies in general populations have also reported statistically significant associations with a number of adverse health effects at low exposures. Cadmium is recognized as a human carcinogen, a classification mainly based on occupational studies of lung cancer. Other cancers have been reported, but dose-response relationships cannot be defined. Cardiovascular disease has been associated with cadmium exposure in recent epidemiological studies, but more evidence is needed in order to establish causality. Adequate evidence of dose-response relationships is available for kidney effects. There is a relationship between cadmium exposure and kidney effects in terms of low molecular mass (LMM) proteinuria. Long-term cadmium exposures with urine cadmium of 2 nmol mmol(-1) creatinine cause such effects in a susceptible part of the population. Higher exposures result in increases in the size of these effects. This assessment is supported by toxicokinetic and toxicodynamic (TKTD) modelling. Associations between urine cadmium lower than 2 nmol mmol-1 creatinine and LMM proteinuria are influenced by confounding by co-excretion of cadmium with protein. A number of epidemiological studies, including some on low exposures, have reported statistically significant associations between cadmium exposure and bone demineralization and fracture risk. Exposures leading to urine cadmium of 5 nmol mmol-1 creatinine and more increase the risk of bone effects. Similar associations at much lower urine cadmium levels have been reported. However, complexities in the cause and effect relationship mean that a no-effect level cannot be defined. LMM proteinuria was selected as the critical effect for cadmium, thus identifying the kidney cortex as the critical organ, although bone effects may occur at exposure levels similar to those giving rise to kidney effects. To avoid these effects, population exposures should not exceed that resulting in cadmium values in urine of more than 2 nmol mmol(-1) creatinine. As cadmium is carcinogenic, a 'safe' exposure level cannot be defined. We therefore recommend that cadmium exposures be kept as low as possible. Because the safety margin for toxic effects in kidney and bone is small, or non-existent, in many populations around the world, there is a need to reduce cadmium pollution globally.

Cadmium exposure and risk of hypertension: a systematic review and dose-response meta-analysis

Effects of Blood Cadmium Levels on Blood Pressure and the Risk of Hypertension in a Community-Based Elderly Population

Cadmium exposure and cardiovascular disease risk: A systematic review and dose-response meta-analysis

Association Between Blood Cadmium Concentrations and Dyslipidemia among Older Adults: A Cross-sectional Study

Cadmium Exposure is Associated with Testosterone Levels in Men: A Cross-Sectional Study from the China National Human Biomonitoring

Arsenic, Lead, Cadmium, Mercury and Hypertension among Asian Populations in the United States: NHANES 2011-2016

Environmental Exposure to Cadmium: Health Risk Assessment and its Associations with Hypertension and Impaired Kidney Function

Association of blood cadmium with all-cause and cause-specific mortality in patients with hypertension

Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population

Association Between Cadmium Exposure and Diabetes Mellitus Risk: a Prisma-Compliant Systematic Review and Meta-Analysis.

Urinary cadmium and mortality from all causes, cancer and cardiovascular disease in the general population: systematic review and meta-analysis of cohort studies

Comparison of event related potentials with and without hypnagogic imagery

Cadmium in biological samples and site-specific cancer risk and mortality: A systematic review of original articles and meta-analyses

Assessment of human exposure to cadmium and its nephrotoxicity in the Chinese population

Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis

The Association Between Blood Pressure and Blood Cadmium in a Chinese Population Living in Cadmium Polluted Area

The Modifying Effect of Kidney Function on the Association of Cadmium Exposure with Blood Pressure and Cardiovascular Mortality: NHANES 1999–2010

Dietary cadmium exposure, risks to human health and mitigation strategies

Mediating effect of telomere length in a hypertension population exposed to cadmium: a case-control study

Risk assessment of effects of cadmium on human health (IUPAC Technical Report)

Benchmark dose estimation of cadmium reference level for hypertension in a Chinese population.